Antiplatelet Therapy and Blood Transfusions in Coronary Surgery with CPB
This study suggests consideration should be given to delaying elective CABG for patients who have received APT treatment until APT is discontinued for at least 5 days.
World's Largest Resource for Cardiovascular Perfusion
This study suggests consideration should be given to delaying elective CABG for patients who have received APT treatment until APT is discontinued for at least 5 days.
NEW YORK (Reuters Health) – In sheep with induced MI, a miniaturized rotary blood pump mounted on a catheter and introduced via […]
SAN FRANCISCO, CA — October 25, 2000 — Treatment with Argatroban injection provided adequate anticoagulation in patients with heparin-induced thrombocytopenia (HIT) who […]